Pilot survey of funders reveals challenges of tracking money; case studies show potential impact of this research on uptake and usability of drugs, diagnostics, vector control products, and vaccines. Read more...
MVI PortfolioWe strategically use our resources to support and advance a range of vaccine approaches that target both humoral and cellular immunity.
Evaluation technology projectsWe partner to develop and optimize new assays and challenge models and support reference and service laboratories.
RTS,SGhana, Kenya, and Malawi to take part in WHO malaria vaccine pilot programme